EBS News and Press, Emergent Biosolutions Inc. From 01/07/26

GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM ...

GAITHERSBURG, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for its Winnipeg, Canada facility to be added as the drug product manufacturin...

GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone HCl) Nasal Spray as the first FDA-approved nasal naloxone spray for emergency trea...

GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) announced today that Dr. Louis W. Sullivan will retire from the company’s Board of Directors effective November 14 after 19 years of service to the company and its shareholders. “For nearly tw...

2025-11-06 23:00:37 ET Investment Overview In my last note on Emergent Biosciences ( EBS ) for Seeking Alpha in June, I reiterated the "Buy" call made in a note dated 8th November 2024 , when stock traded at $11 per share.... Read the full article on Seeking Alpha ...

A look at the top 10 most actives in the United States Intensity Therapeutics Inc. (INTS) rose 394.6% to $1.32 on volume of 1,376,488,997 shares Harvard Bioscience Inc. (HBIO) rose 41.1% to $0.63 on volume of 301,574,010 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 3.7% to...

2025-10-30 10:15:17 ET DENVER, Colo., Oct 30, 2025 ( 247marketnews.com )- The biotech and life sciences sector is taking center stage this morning as investors digest a series of breakthroughs spanning oncology, obesity, sustainable materials, and advanced biologics. From Intensity Ther...

A look at the top 10 most actives in the United States Intensity Therapeutics Inc. (INTS) rose 173.4% to $0.7297 on volume of 385,641,574 shares Cambium Networks Corporation (CMBM) rose 88.1% to $5.55 on volume of 100,908,607 shares Harvard Bioscience Inc. (HBIO) rose 23.1% to $0.5498 on vo...

2025-10-29 20:57:24 ET More on Emergent Biosolutions Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript Emergent...

2025-10-29 20:56:30 ET Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call October 29, 2025 5:00 PM EDT... Read the full article on Seeking Alpha For further details see: Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript